Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chailleux, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chailleux, E.
(Chest. 1996;109:741-749.)
© 1996 American College of Chest Physicians

Predictors of Survival in Patients Receiving Domiciliary Oxygen Therapy or Mechanical Ventilation

A 10-Year Analysis of ANTADIR Observatory

Edmond Chailleux MD1; Brigitte Fauroux MD1; Françoise Binet 1; Bertrand Dautzenberg MD1; Jean-Marie Polu MD1; and ;Observatory Group of ANTADIR1

1 From the Association Nationale pour le Traitement à Domicile de l'Insuffisance Respiratoire Chronique Grave (ANTADIR), Paris, France

Study objective: To analyze predictors of survival for patients receiving home long-term oxygen therapy (LTOT) or prolonged mechanical ventilation (PMV) according to the cause of chronic respiratory insufficiency (CRI) and the patient's physiologic data.

Design: Analysis of a nationwide database (ANTADIR Observatory).

Setting: The national nonprofit network for home treatment of patients with CRI Association Nationale pour le Traitement à Domicile de l'Insuffisance Respiratoire Chronique (ANTADIR): founded in France in the 1980s.

Patients: There were 26,140 patients receiving LTOT or PMV (noninvasive or via tracheostomy) between January 1, 1984 and January 1, 1993 (chronic bronchitis, 12,043; asthma, 1,755; bronchiectasis, 1,556; emphysema, 551; tuberculosis sequelae, 4,147; kyphoscoliosis, 1,574; neuromuscular diseases, 1,097; pneumoconiosis, 919; and fibrosis, 2,498).

Measurements and results: Survival analysis was performed using the actuarial and the Cox's semiparametric model. The mean survival for patients with chronic bronchitis is 3 years. Survival is slightly better for patients with bronchiectasis and asthma and worse for those with emphysema. Patients with kyphoscoliosis and a neuromuscular disease have the longest survival (8 and 6.5 years, respectively). Patients with CRI due to tuberculosis sequelae experience the same survival as COPD patients (3 years). Prognosis is the worst in patients with pneumoconiosis or fibrosis: 50% of these patients die during the year following the beginning of home treatment. The association of an obstructive lung disease worsens the prognosis of patients with kyphoscoliosis or neuromuscular disease and tends to bring the survival rate of the patients with pneumoconiosis or fibrosis closer to that of COPD patients. In COPD, male sex, older age, lower body mass index (BMI), FEV1 percent predicted, PaO2, and PaCO2 are independent negative prognostic factors. For tuberculous sequelae and kyphoscoliosis, female sex, younger age, a high BMI, PaO2, and PaCO2 (and for kyphoscoliosis a higher FEV1/vital capacity [VC] ratio) are all independent favorable prognostic factors. In pulmonary fibrosis, a lower PaO2 and PaCO2 values, a lower VC percent predicted, and a higher FEV1/VC ratio are negative prognostic factors.

Conclusions: The ANTADIR Observatory allows a unique opportunity to analyze long-term survival of a large population with CRI treated at home.

Key Words: chronic respiratory insufficiency • domiciliary care • home care • home health • home respiratory care • mechanical ventilation • oxygen therapy • survival

Submitted on May 9, 1995
Accepted on October 5, 2007




This article has been cited by other articles:


Home page
ChestHome page
S. P. Haranath, B. S. Park, M. Osborne, S. Budweiser, and R. A. Jorres
Body Mass Index in COPD Mortality: Is It All in the Water?
Chest, January 1, 2008; 133(1): 318 - 319.
[Full Text] [PDF]


Home page
ChestHome page
M. Alakhras, P. A. Decker, H. F. Nadrous, M. Collazo-Clavell, and J. H. Ryu
Body Mass Index and Mortality in Patients With Idiopathic Pulmonary Fibrosis
Chest, May 1, 2007; 131(5): 1448 - 1453.
[Abstract] [Full Text] [PDF]


Home page
Chronic Respiratory DiseaseHome page
D Veale
Chronic respiratory care and rehabilitation in France
Chronic Respiratory Disease, November 1, 2006; 3(4): 215 - 216.
[Abstract] [PDF]


Home page
Eur Respir JHome page
M. Toussaint, M. Steens, G. Wasteels, and P. Soudon
Diurnal ventilation via mouthpiece: survival in end-stage Duchenne patients
Eur. Respir. J., September 1, 2006; 28(3): 549 - 555.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
G. Knoll, S. Cockfield, T. Blydt-Hansen, D. Baran, B. Kiberd, D. Landsberg, D. Rush, E. Cole, and for The Kidney Transplant Working Group of the Can
Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation
Can. Med. Assoc. J., November 8, 2005; 173(10): S1 - S25.
[Full Text] [PDF]


Home page
ChestHome page
J. J. Soler-Cataluna, L. Sanchez-Sanchez, M. A. Martinez-Garcia, P. R. Sanchez, E. Salcedo, and M. Navarro
Mid-Arm Muscle Area Is a Better Predictor of Mortality Than Body Mass Index in COPD
Chest, October 1, 2005; 128(4): 2108 - 2115.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. J. Lloyd-Owen, G. C. Donaldson, N. Ambrosino, J. Escarabill, R. Farre, B. Fauroux, D. Robert, B. Schoenhofer, A. K. Simonds, and J. A. Wedzicha
Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey
Eur. Respir. J., June 1, 2005; 25(6): 1025 - 1031.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
S. I. Rennard
Clinical Approach to Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease
Proceedings of the ATS, April 1, 2005; 2(1): 94 - 100.
[Abstract] [Full Text] [PDF]


Home page
Clin RehabilHome page
T. J Ringbaek and P. Lange
Outdoor activity and performance status as predictors of survival in hypoxaemic chronic obstructive pulmonary disease (COPD)
Clinical Rehabilitation, March 1, 2005; 19(3): 331 - 338.
[Abstract] [PDF]


Home page
ChestHome page
N. J. M. Cano, C. Pichard, H. Roth, I. Court-Fortune, L. Cynober, M. Gerard-Boncompain, A. Cuvelier, J.-P. Laaban, J.-C. Melchior, J.-C. Raphael, et al.
C-Reactive Protein and Body Mass Index Predict Outcome in End-Stage Respiratory Failure
Chest, August 1, 2004; 126(2): 540 - 546.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Dupont, A. Gacouin, H. Lena, S. Lavoue, G. Brinchault, P. Delaval, and R. Thomas
Survival of Patients With Bronchiectasis After the First ICU Stay for Respiratory Failure
Chest, May 1, 2004; 125(5): 1815 - 1820.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H.-N. Shen, J.-S. Jerng, C.-J. Yu, and P.-C. Yang
Outcome of Coal Worker's Pneumoconiosis With Acute Respiratory Failure
Chest, March 1, 2004; 125(3): 1052 - 1058.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. H. Kollef
Tracheostomy for Respiratory Failure: We Need More Answers
Chest, January 1, 2004; 125(1): 7 - 9.
[Full Text] [PDF]


Home page
Eur Respir JHome page
B. Buyse, W. Meersseman, and M. Demedts
Treatment of chronic respiratory failure in kyphoscoliosis: oxygen or ventilation?
Eur. Respir. J., September 1, 2003; 22(3): 525 - 528.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. Chailleux, J.-P. Laaban, and D. Veale
Prognostic Value of Nutritional Depletion in Patients With COPD Treated by Long-term Oxygen Therapy: Data From the ANTADIR Observatory
Chest, May 1, 2003; 123(5): 1460 - 1466.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. Prigent, C. Samuel, B. Louis, M.-F. Abinun, F. Zerah-Lancner, M. Lejaille, J.-C. Raphael, and F. Lofaso
Comparative Effects of Two Ventilatory Modes on Speech in Tracheostomized Patients with Neuromuscular Disease
Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 114 - 119.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
N.J.M. Cano, H. Roth, I. Court-Fortune, L. Cynober, M. Gerard-Boncompain, A. Cuvelier, J-P. Laaban, J-C. Melchior, C. Pichard, J-C. Raphael, et al.
Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation
Eur. Respir. J., July 1, 2002; 20(1): 30 - 37.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. I. Harik-Khan, J. L. Fleg, and R. A. Wise
Body Mass Index and the Risk of COPD
Chest, February 1, 2002; 121(2): 370 - 376.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Corrado, M. Confalonieri, S. Marchese, C. Mollica, G. Villella, M. Gorini, and R. Della Porta
Iron Lung vs Mask Ventilation in the Treatment of Acute on Chronic Respiratory Failure in COPD Patients : A Multicenter Study
Chest, January 1, 2002; 121(1): 189 - 195.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. F. HANSEN, J. VESTBO, K. PHANARETH, A. KOK-JENSEN, and A. DIRKSEN
Peak Flow as Predictor of Overall Mortality in Asthma and Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 690 - 693.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. Casanova, B. R. Celli, L. Tost, E. Soriano, J. Abreu, V. Velasco, and F. Santolaria
Long-term Controlled Trial of Nocturnal Nasal Positive Pressure Ventilation in Patients With Severe COPD
Chest, December 1, 2000; 118(6): 1582 - 1590.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J D ROAD
Assisted ventilation for chronic neuromuscular disorders
Thorax, January 1, 2000; 55(1): 1 - 2.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American College of Chest Physicians.